Track your comments!
[x]


When you register, comments on your articles and replies to your comments appear here. Register Now!

Sign in to your account
[x]

Not a Scientific Blogging member yet?

Register Now for a Free Scientificblogging.com Account

  • Customize your profile with pictures, banner, a blogroll and more.
  • Leave comments on articles, add other members to your friend lists, chat with people on the site.
  • Write blog posts that can be seen by hundreds of thousands of readers.

It's free and it only takes a minute!

Already a Scientific Blogging member?

Sign In Now

Banner
By News Staff | September 3rd 2008 12:00 AM | 1 comment | Print | E-mail | Track Comments
Today there is rapidly growing interest in 'intelligent' computer-based methods that use various classes of measurement signals, from different patient samples, for instance, to create a model for classifying new observations. This type of method is the basis for many technical applications, such as recognition of human speech, images, and fingerprints, and is now also beginning to attract new fields such as health care.

These 'intelligent' computer-based methods for classifying patient samples have been evaluated by Swedish researchers at Uppsala University with the help of two methods that have completely dominated research for 25 years; cross validation and resampling/bootstrapping.

Their conclusion; they're worthless for practical problems.

"Especially in applications in which faulty classification decisions can lead to catastrophic consequences, such as choosing the wrong form of therapy for treating cancer, it is extremely important to be able to make a reliable estimate of the performance of the classification model," explains Mats Gustafsson, Professor of signal processing and medical bioinformatics at Uppsala University, who co-directed the new study together with Associate Professor Anders Isaksson.

To evaluate the performance of a classification model, one normally tests it on a number of trial examples that have never been involved in the design of the model. Unfortunately there are seldom tens of thousands of test examples available for this type of evaluation. In biomedicine, for instance, it is often expensive and difficult to collect the patient samples needed, especially if one wishes to analyze a rare disease. To solve this problem, many different methods have been proposed. Since the 1980s two methods have completely dominated research, namely, cross validation and resampling/bootstrapping.

"This has entailed that the performance assessment of virtually all new methods and applications reported in the scientific literature in the last 25 years has been carried out using one of these two methods," says Mats Gustafsson.

In the new study, the Uppsala researchers use both theory and convincing computer simulations to show that this methodology is worthless in practice when the total number of examples is small in relation to the natural variation that exists among different observations. What is considered a small number depends in turn on what problem is being studied-in other words, it is impossible to determine whether the number of examples is sufficient.

"Our main conclusion is that this methodology cannot be depended on at all, and that it therefore needs to be immediately replaced by Bayesian methods, for example, which can deliver reliable measures of the uncertainty that exists. Only then will multivariate analyses be in any position to be adopted in such critical applications as health care," says Mats Gustafsson.

Article: A. Isaksson, M. Wallman, H. Göransson, M.G. Gustafsson Cross-validation and bootstrapping are unreliable in small sample classification, Pattern Recognition Letters Volume 29, Issue 14, Pages 1960-1965 (15 October 2008)

Comments

Interesting! So is the suggestion here that if your sample size is small, the 'noise' you get from sub-dividing the sample (ie. when cross-validating) is so big that it swamps the uncertainties in your analysis. And therefore renders the analysis useless.

I'm definitely pro-Bayes :-). I guess this doesn't quite mean we should drop cross-validation and boot-strapping, though! Sounds like you just need to be aware that there's a point (with small samples) where they're no longer useful.

And of course, it's worth considering using Bayesian techniques in any case :-)

Add a comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <sup> <sub> <a> <em> <strong> <center> <cite> <code> <TH><ul> <ol> <li> <dl> <dt> <dd> <img> <br> <p> <blockquote> <strike> <object> <param> <embed> <del> <pre> <b> <i> <table> <tbody> <div> <tr> <td> <h1> <h2> <h3> <h4> <h5> <h6> <hr> <iframe>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.
CAPTCHA
If you register, you will never be bothered to prove you are human again. And you get a real editor toolbar to use instead of this HTML thing that wards off spam bots.